The MONALEESA-2 trial - report from ESMO2021

from Medical Digest & Congress Report · host Medical Congress News

Prof. Gabriel N. Hortobagyi speaks about the overall survival results from the phase III MONALEESA-2 trial of postmenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative advanced breast cancer treated with endocrine therapy ± ribociclib. Video: https://congressreport.eu/scientific-contents/interview:monaleesa-2-trial

Episode metadata supplied by the publisher feed · Published Sep 30, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

The MONALEESA-2 trial - report from ESMO2021

0:00 8:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 8 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on September 30, 2021.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!